aTyr Pharma, Inc. (ATYR)
NASDAQ: ATYR · Real-Time Price · USD
0.8363
+0.0117 (1.42%)
At close: Oct 7, 2025, 4:00 PM EDT
0.8304
-0.0059 (-0.71%)
After-hours: Oct 7, 2025, 7:59 PM EDT
aTyr Pharma Employees
As of December 31, 2024, aTyr Pharma had 65 total employees, including 56 full-time and 9 part-time employees. The number of employees increased by 6 or 10.17% compared to the previous year.
Employees
65
Change (1Y)
6
Growth (1Y)
10.17%
Revenue / Employee
n/a
Profits / Employee
-$1,025,185
Market Cap
81.95M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 65 | 6 | 10.17% |
Dec 31, 2023 | 59 | -11 | -15.71% |
Dec 31, 2022 | 70 | 17 | 32.08% |
Dec 31, 2021 | 53 | 10 | 23.26% |
Dec 31, 2020 | 43 | -1 | -2.27% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
ATYR News
- 4 days ago - aTyr Pharma, Inc. (ATYR) Faces Investor Scrutiny After EFZO-FIT Study Failure Drives Shares 80% Lower – Hagens Berman - GlobeNewsWire
- 7 days ago - Ethos Technologies Targets IPO Amid Positive Insurance Offerings - Seeking Alpha
- 7 days ago - aTyr Pharma, Inc. (ATYR) Faces Investor Scrutiny After EFZO-FIT Study Failure Drives Shares 80% Lower -- Hagens Berman - GlobeNewsWire
- 7 days ago - aTyr Pharma Presents Additional Findings from Phase 3 EFZO-FIT™ Study in Late-Breaking Oral Abstract at the European Respiratory Society (ERS) Congress 2025 - GlobeNewsWire
- 11 days ago - Ethos Files Registration Statement for Proposed Initial Public Offering - GlobeNewsWire
- 14 days ago - aTyr Pharma, Inc. (ATYR) Faces Investor Scrutiny After EFZO-FIT™ Study Failure Drives Shares 80% Lower -- Hagens Berman - PRNewsWire
- 15 days ago - aTyr Pharma, Inc. (ATYR) Faces Investor Scrutiny After EFZO-FIT Study Failure Drives Shares 80% Lower -- Hagens Berman - GlobeNewsWire
- 18 days ago - Top 3 Health Care Stocks That May Explode In September - Benzinga